$RKLB

Kampani Arjun sold $14.2M of RKLB

Kampani Arjun (SVP & General Counsel) sold 98,668 shares of Rocket Lab Corp (RKLB) at an average of $144.38 ($139.41–$150.00, $14.25M total) across 8 trades over 2026-05-26 to 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Kampani Arjun
Published May 28, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:47 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RKLB
Neutral
medium confidence
Mentioned
$RKLB
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

The disclosure provides a concrete, time-stamped insider selling event (open-market sale) and the approximate dollar value, but it does not include new operational or financial guidance.

02

Market read

For RKLB, the only new tradable input is the insider sale size and timing; it is unlikely to change the fundamental thesis by itself.

03

What to watch

Traders may over-weight insider sales; the key nuance here is that the plan is pre-arranged, and the trades occurred days before the filing date.

Relevance 6/10Novelty 4/10Timing: filed 2026-05-28, covering sales on 2026-05-26 to 2026-05-27

Background

This is an SEC Form 4 insider transaction disclosure for Rocket Lab Corp, reported by SVP and General Counsel Kampani Arjun.

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

Rocket Lab Form 4 shows SVP and General Counsel Kampani Arjun sold 98,668 shares in open-market trades totaling about $14.25M.

Expected impact

Likely limited, short-lived impact unless paired with other company-specific catalysts.

Evidence & confidence

The filing is a primary-source Form 4 and the sale size is material, but the presence of a pre-arranged 10b5-1 plan reduces interpretive signal about near-term business outlook.

Market effects

Minimal direct read-through to the space/launch sector from a single 10b5-1 insider sale.

None.

None.

Counterpoint

The sale could be purely liquidity-driven under the 10b5-1 plan, implying no actionable bearish signal for RKLB fundamentals.

Key entities

  • Rocket Lab Corp

    Subject of the Form 4 insider transaction disclosure.

  • Kampani Arjun

    SVP and General Counsel who executed the open-market sales under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBMed

Is RKLB Stock A Buy Or A High-Beta Trap?

Rocket Lab (RKLB) trades at $66, down 56% from its 52-week high, with a high P/S ratio. Q2 2026 revenue was $234M, up 62% YoY, mainly from Space Systems. Neutron rocket launch and Iridium acquisition are delayed. Backlog is $2.36B. Management expects slow growth from Iridium.

$RKLBHighAI 8/10

Rocket Lab Falls 6% as SpaceX Flags Iridium Deal to the FCC, Intuitive Machines Slides 5%

Rocket Lab (RKLB) fell 6% to $63.82 after SpaceX filed an FCC complaint against Iridium, which could impact Rocket Lab's $8B acquisition. The deal's variable exchange ratio ties Iridium payouts to Rocket Lab's share price, amplifying regulatory risks. Intuitive Machines (LUNR) and AST SpaceMobile (ASTS) also slid 5% and 6% respectively, following broader sector weakness.

$RKLBHighAI 9/10

Rocket Lab's HASTE Is Flying Hypersonic Missions for the Pentagon. Here's the Defense Business Hiding Inside a Space Stock.

Rocket Lab (RKLB), a smaller competitor to SpaceX (SPCX), has developed HASTE, a suborbital launch vehicle for hypersonic testing, primarily for the Department of Defense. HASTE offers lower-cost, frequent testing, generating higher revenue per flight than standard Electron launches. Rocket Lab has secured around $500 million in HASTE contracts, contributing significantly to its projected 2026 revenue. The company also operates in satellite manufacturing and plans to expand with the acquisition

$INTCHighAI 8/10

Why Are Nasdaq, Dow Futures Trading Mixed Premarket? INTC, SLS, SPCX, RKLB, ASTS, RIOT, FRMI Stocks Are In Focus

U.S. stock futures were mixed on Tuesday, with Nasdaq and Russell 2000 futures up 0.1%, Dow futures down 0.1%, and S&P 500 futures flat. Investors await July CPI data and geopolitical tensions impact sentiment. Key earnings reports include SMCI, CRWV, CAVA, LITE, and SLS. NVDA labeled AI data centers as investable assets, INTC upsized its share sale to $20B, and RIOT secured a $9.1B deal. RKLB shares fell despite a revenue beat, ASTS extended selloff, and SPCX faced lockup expiration pressures.

$RKLBMedAI 8/10

Rocket Lab Stock: Bull vs. Bear

Rocket Lab (RKLB +2.04%) reported record revenue of $234M in Q2 2026, up 62% YoY, with a backlog of $2.36B. The company secured U.S. Space Force contracts but delayed its Neutron rocket launch. Despite growth, it trades at 51x sales and reported a $49M net loss in Q2. Neutron's success is critical for future profitability.